Medical Xpress news

Medical Xpress / AI model identifies how every country can improve its cancer outcomes

For the first time, researchers have used machine learning—a type of artificial intelligence (AI)—to identify the most important drivers of cancer survival in nearly all the countries in the world.

Jan 13, 2026 in Oncology & Cancer
Medical Xpress / Study finds non-hallucinogenic psilocybin neural receptor: A novel target for treating depression and anxiety

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and anxiety. But the chemical's hallucinogenic effects ...

Jan 13, 2026 in Psychology & Psychiatry
Medical Xpress / Schizophrenia: The cerebellum's unexpected role

Apathy, social withdrawal, and loss of motivation—the so-called ''negative'' symptoms of schizophrenia—are among the most disabling and hardest to treat. A team from the University of Geneva (UNIGE) has uncovered the ...

Jan 13, 2026 in Psychology & Psychiatry
Medical Xpress / A new diet option for mild-to-moderate Crohn's disease

"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors.

Jan 13, 2026 in Inflammatory disorders
Medical Xpress / Genetic risk factor and viral infection jointly contribute to multiple sclerosis, study suggests

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its progression.

Jan 13, 2026 in Genetics
Medical Xpress / New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data show

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis—a dangerous, disease-induced ...

Medical Xpress / When a virus releases the immune brake: New evidence on the onset of multiple sclerosis

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now identified how the Epstein-Barr ...

Jan 13, 2026 in Neuroscience
Medical Xpress / Immune response to Epstein-Barr virus linked to brain damage in multiple sclerosis

The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple sclerosis (MS), according to new research from Karolinska Institutet, published in Cell. The study provides ...

Medical Xpress / Brain neurons process salience, valence and value separately to understand what is important—and what isn't

The sound of a fire alarm tells us to get out quickly to not get hurt, while the sight of a gas station sign can signal a chance to refuel. In everyday life, we learn to link cues we sense with what they mean, helping us ...

Jan 13, 2026 in Psychology & Psychiatry
Medical Xpress / Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the potential to overcome treatment ...

Jan 13, 2026 in Oncology & Cancer
Medical Xpress / Fruit fly pigmentation guides discovery of genes that control brain dopamine and sleep

Dopamine in the brain influences movement, learning, motivation and sleep. In humans, problems with dopamine are linked to conditions like Parkinson's disease, depression and sleep disorders. While scientists know a great ...

Jan 13, 2026 in Genetics
Medical Xpress / Night-time changes in metabolism may be driving common liver disease

Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body ...